| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Supplement |
1 From the Gastroenterology Department, Hôpital Europèen Georges Lompidou, Assistance Publique des Hôpitaux de Paris and Paris V University, Paris, and the Institute of Physiology and Biochemistry of Nutrition, Federal Dairy Research Center, Kiel, Germany.
Probiotics are nonpathogenic microorganisms that, when ingested, exert a positive influence on the health or physiology of the host. They can influence intestinal physiology either directly or indirectly through modulation of the endogenous ecosystem or immune system. The results that have been shown with a sufficient level of proof to enable probiotics to be used as treatments for gastrointestinal disturbances are 1) the good tolerance of yogurt compared with milk in subjects with primary or secondary lactose maldigestion, 2) the use of Saccharomyces boulardii and Enterococcus faecium SF 68 to prevent or shorten the duration of antibiotic-associated diarrhea, 3) the use of S. boulardii to prevent further recurrence of Clostridium difficile–associated diarrhea, and 4) the use of fermented milks containing Lactobacillus rhamnosus GG to shorten the duration of diarrhea in infants with rotavirus enteritis (and probably also in gastroenteritis of other causes). Effects that are otherwise suggested for diverse probiotics include alleviation of diarrhea of miscellaneous causes; prophylaxis of gastrointestinal infections, which includes traveler's diarrhea; and immunomodulation. Trials of gastrointestinal diseases that involve the ecosystem are currently being performed, eg, Helicobacter pylori infections, inflammatory bowel disease, and colon cancer.
Key Words: Probiotics • bifidobacteria • lactobacilli • intestinal infections • antibiotic-associated diarrhea • gastroenteritis • traveler's diarrhea • intestinal flora • inflammatory bowel disease • colon cancer
This article has been cited by other articles:
|
|
 |
|
  J. P. Chouraqui, D. Grathwohl, J. M. Labaune, J. M. Hascoet, I. de Montgolfier, M. Leclaire, M. Giarre, and P. Steenhout Assessment of the safety, tolerance, and protective effect against diarrhea of infant formulas containing mixtures of probiotics or probiotics and prebiotics in a randomized controlled trial Am. J. Clinical Nutrition, May 1, 2008; 87(5): 1365 - 1373. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. A. Ching, K. Gura, B. Modi, and T. Jaksic Pediatric Intestinal Failure: Nutrition, Pharmacologic, and Surgical Approaches Nutr Clin Pract, December 1, 2007; 22(6): 653 - 663. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. de Vrese and P. R. Marteau Probiotics and Prebiotics: Effects on Diarrhea J. Nutr., March 1, 2007; 137(3): 803S - 811S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Drisko, B. Bischoff, M. Hall, and R. McCallum Treating Irritable Bowel Syndrome with a Food Elimination Diet Followed by Food Challenge and Probiotics J. Am. Coll. Nutr., December 1, 2006; 25(6): 514 - 522. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. De Preter, T. Coopmans, P. Rutgeerts, and K. Verbeke Influence of Long-Term Administration of Lactulose and Saccharomyces Boulardii on the Colonic Generation of Phenolic Compounds in Healthy Human Subjects J. Am. Coll. Nutr., December 1, 2006; 25(6): 541 - 549. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Dray and P. Marteau The Use of Enteral Nutrition in the Management of Crohn's Disease in Adults JPEN J Parenter Enteral Nutr, July 1, 2005; 29(4_suppl): S166 - S172. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. M. Corcoran, C. Stanton, G. F. Fitzgerald, and R. P. Ross Survival of Probiotic Lactobacilli in Acidic Environments Is Enhanced in the Presence of Metabolizable Sugars Appl. Envir. Microbiol., June 1, 2005; 71(6): 3060 - 3067. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. R. Heiser, J. A. Ernst, J. T. Barrett, N. French, M. Schutz, and M. P. Dube Probiotics, Soluble Fiber, and L-Glutamine (GLN) Reduce Nelfinavir (NFV)or Lopinavir/Ritonavir (LPV/r)-related Diarrhea J Int Assoc Physicians AIDS Care (Chic Ill), October 1, 2004; 3(4): 121 - 129. [Abstract] [PDF]
|
|
|
|
 |
|
 D. Ma, P. Forsythe, and J. Bienenstock Live Lactobacillus reuteri Is Essential for the Inhibitory Effect on Tumor Necrosis Factor Alpha-Induced Interleukin-8 Expression Infect. Immun., September 1, 2004; 72(9): 5308 - 5314. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Baharav, F. Mor, M. Halpern, and A. Weinberger Lactobacillus GG Bacteria Ameliorate Arthritis in Lewis Rats J. Nutr., August 1, 2004; 134(8): 1964 - 1969. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. K. Lutter and K. G. Dewey Proposed Nutrient Composition for Fortified Complementary Foods J. Nutr., September 1, 2003; 133(9): 3011S - 3020. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Millar, M Wilks, and K Costeloe Probiotics for preterm infants? Arch. Dis. Child. Fetal Neonatal Ed., September 1, 2003; 88(5): F354 - F358. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Dahan, G. Dalmasso, V. Imbert, J.-F. Peyron, P. Rampal, and D. Czerucka Saccharomyces boulardii Interferes with Enterohemorrhagic Escherichia coli-Induced Signaling Pathways in T84 Cells Infect. Immun., February 1, 2003; 71(2): 766 - 773. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Yan and D. B. Polk Probiotic Bacterium Prevents Cytokine-induced Apoptosis in Intestinal Epithelial Cells J. Biol. Chem., December 20, 2002; 277(52): 50959 - 50965. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Kimura, Y. Nagata, C. W. Bryant, and R. K. Buddington Nondigestible Oligosaccharides Do Not Increase Accumulation of Lipid Soluble Environmental Contaminants by Mice J. Nutr., January 1, 2002; 132(1): 80 - 87. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Schrezenmeir and M. de Vrese Probiotics, prebiotics, and synbiotics--approaching a definition Am. J. Clinical Nutrition, February 1, 2001; 73(2): 361S - 364. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
